The Southeast BIO Investor & Partnering Forum is extremely pleased to announce that Dennis Purcell will be our Keynote Speaker at the 21st annual conference on Thursday, November 7 in Miami. Mr. Purcell is the original Founder of Aisling Capital LLC and currently serves as a Senior Advisor to Aisling. Previously, he served as the Senior Managing Partner. Prior to Aisling Capital, Mr. Purcell served as Managing Director of the Life Sciences Investment Banking Group at Chase H&Q (formerly Hambrecht & Quist, “H&Q”). While at H&Q, he was directly involved with over two hundred completed transactions and supervised over $10 billion of financing and advisory assignments in the pharmaceutical, biotechnology and medical products industries.
Mr. Purcell is a frequent commentator on the industry and has been honored in the “Biotech Hall of Fame” by Genetic Engineering News, named to the Biotechnology All-Stars list by Forbes ASAP, honored as one of the top 50 Irish-American businessmen and cited as one of the top 100 contributors to the biotechnology industry.
Mr. Purcell has served as a director of Aton Pharma, Bridge Pharmaceuticals, Cengent Therapeutics, Dynova Laboratories, Paratek Pharmaceuticals, Valentis and Xanodyne Pharmaceuticals. He has also served on the boards of Biotechnology Industry Association, Harvard Kennedy School – M-R CBG Advisory Council, the Irvington Institute and on the Board of L.E.K. Consulting. He currently sits on the board of Real Endpoints, Summus Global, Inc., Life Science Leader Magazine – Editorial Advisory Board, NY BIO Association and is a member of The University of Delaware Investment Visiting Committee Member and The University of Delaware Lerner College NYC Dean’s Council.
Mr. Purcell received his M.B.A. from Harvard Business School and his B.S. in Accounting from the University of Delaware